Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of 27.30 billion. The enterprise value is 28.94 billion.
Market Cap | 27.30B |
Enterprise Value | 28.94B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 347.12M |
Valuation Ratios
The trailing PE ratio is 86.22.
PE Ratio | 86.22 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 22.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.78, with an EV/FCF ratio of 41.01.
EV / Earnings | 91.41 |
EV / Sales | 6.97 |
EV / EBITDA | 24.78 |
EV / EBIT | 31.85 |
EV / FCF | 41.01 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.73 |
Quick Ratio | 1.05 |
Debt / Equity | 0.16 |
Debt / EBITDA | 1.66 |
Debt / FCF | 2.64 |
Interest Coverage | 10.48 |
Financial Efficiency
Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.
Return on Equity (ROE) | 4.67% |
Return on Assets (ROA) | 5.54% |
Return on Invested Capital (ROIC) | 6.61% |
Return on Capital Employed (ROCE) | 5.97% |
Revenue Per Employee | 375,056 |
Profits Per Employee | 29,918 |
Employee Count | 10,582 |
Asset Turnover | 0.40 |
Inventory Turnover | 3.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.49% in the last 52 weeks. The beta is 0.57, so Novonesis's price volatility has been lower than the market average.
Beta (5Y) | 0.57 |
52-Week Price Change | -0.49% |
50-Day Moving Average | 58.00 |
200-Day Moving Average | 61.55 |
Relative Strength Index (RSI) | 49.55 |
Average Volume (20 Days) | 14,801 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of 3.97 billion and earned 316.60 million in profits. Earnings per share was 1.14.
Revenue | 3.97B |
Gross Profit | 2.06B |
Operating Income | 872.66M |
Pretax Income | 431.83M |
Net Income | 316.60M |
EBITDA | 1.12B |
EBIT | 872.66M |
Earnings Per Share (EPS) | 1.14 |
Balance Sheet
The company has 289.89 million in cash and 1.86 billion in debt, giving a net cash position of -1.57 billion.
Cash & Cash Equivalents | 289.89M |
Total Debt | 1.86B |
Net Cash | -1.57B |
Net Cash Per Share | n/a |
Equity (Book Value) | 11.57B |
Book Value Per Share | 41.64 |
Working Capital | 819.03M |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -350.24 million, giving a free cash flow of 705.66 million.
Operating Cash Flow | 1.06B |
Capital Expenditures | -350.24M |
Free Cash Flow | 705.66M |
FCF Per Share | n/a |
Margins
Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.
Gross Margin | 52.00% |
Operating Margin | 21.99% |
Pretax Margin | 10.88% |
Profit Margin | 7.98% |
EBITDA Margin | 28.23% |
EBIT Margin | 21.99% |
FCF Margin | 17.78% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.60%.
Dividend Per Share | 0.35 |
Dividend Yield | 0.60% |
Dividend Growth (YoY) | -63.27% |
Years of Dividend Growth | n/a |
Payout Ratio | 81.65% |
Buyback Yield | -0.64% |
Shareholder Yield | -0.05% |
Earnings Yield | 1.16% |
FCF Yield | 2.59% |
Stock Splits
The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.
Last Split Date | Dec 9, 2011 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Novonesis has an Altman Z-Score of 5.27.
Altman Z-Score | 5.27 |
Piotroski F-Score | n/a |